International Peanut Allergy Prevention, 6 Years After the Learning Early About Peanut Study.
J Allergy Clin Immunol Pract
; 10(1): 71-77, 2022 01.
Article
em En
| MEDLINE
| ID: mdl-34311123
ABSTRACT
Six years ago, the Learning Early About Peanut (LEAP) trial findings helped fundamentally shift the paradigm of peanut allergy prevention. Although the results of LEAP are well accepted, policy-makers, caregivers, and clinicians struggle with how best to implement and apply the study's key findings in clinical practice. Differences in guidelines highlight issues related to peanut allergy prevention implementation, including caregiver acceptability, cost, fidelity, feasibility, appropriateness, and adoption. The goals of this rostrum are to review how the LEAP study has informed international peanut allergy prevention policy, as well as to review the strengths and ongoing controversies in peanut allergy prevention implementation.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Hipersensibilidade a Amendoim
Tipo de estudo:
Guideline
/
Prognostic_studies
Limite:
Humans
/
Infant
Idioma:
En
Revista:
J Allergy Clin Immunol Pract
Ano de publicação:
2022
Tipo de documento:
Article
País de afiliação:
Canadá